IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome

被引：46

作者：

Laron, Zvi ^{[1
]}

Kauli, Rivka ^{[1
]}

Lapkina, Lena ^{[2
]}

Werner, Haim ^{[2
]}

机构：

[1] Schneider Childrens Med Ctr, Endocrinol & Diabet Res Unit, Petah Tiqwa, Israel

[2] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel

来源：

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH | 2017年 / 772卷

基金：

以色列科学基金会;

关键词：

GROWTH-FACTOR-I; HORMONE RECEPTOR GENE; FAMILIAL DWARFISM; TREATED PATIENTS; INSENSITIVITY SYNDROME; PITUITARY DWARFISM; BODY-COMPOSITION; MOLECULAR-BASIS; FACTOR (IGF)-I; ADULT PATIENTS;

D O I：

10.1016/j.mrrev.2016.08.002

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Laron syndrome (LS) is a unique model of congenital IGF-I deficiency. It is characterized by dwarfism and obesity, and is caused by deletion or mutations of the growth hormone receptor (GH-R) gene. It is hypothesized that LS is an old disease originating in Indonesia and that the mutated gene spread to South Asia, the Middle East, the Mediterranean region and South America. (C) 2016 Elsevier B.V. All rights reserved.

引用

页码：123 / 133

页数：11

共 115 条

[1]

ABRAMOVICI A, 1983, ISRAEL J MED SCI, V19, P515

[2] IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation [J].

Abuzzahab, MJ ;

Schneider, A ;

Goddard, A ;

Grigorescu, F ;

Lautier, C ;

Keller, E ;

Kiess, W ;

Klammt, J ;

Kratzsch, J ;

Osgood, D ;

Pfäffle, R ;

Raile, K ;

Seidel, B ;

Smith, RJ ;

Chernausek, SD ;

Frank, GR ;

Kaplowitz, PB ;

Pescovitz, OH ;

Smith, EP .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (23) :2211-2222

[3] OCCURRENCE OF 4 TYPES OF GROWTH-HORMONE RELATED DWARFISM IN ISRAELI COMMUNITIES [J].

ADAM, A ;

JOSEFSBERG, Z ;

PERTZELAN, A ;

ZADIK, Z ;

CHEMKE, JM ;

LARON, Z .

EUROPEAN JOURNAL OF PEDIATRICS, 1981, 137 (01) :35-39

[4] LARON DWARFISM AND MUTATIONS OF THE GROWTH HORMONE-RECEPTOR GENE [J].

AMSELEM, S ;

DUQUESNOY, P ;

ATTREE, O ;

NOVELLI, G ;

BOUSNINA, S ;

POSTELVINAY, MC ;

GOOSSENS, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (15) :989-995

[5]

Arad I., 1977, P 1 INT C AUX ROM, P159

[6] Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: A clinical research center study [J].

Backeljauw, PF ;

Underwood, LE .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1504-1510

[7] Adult and Near-Adult Height in Patients with Severe Insulin-Like Growth Factor-I Deficiency after Long-Term Therapy with Recombinant Human Insulin-Like Growth Factor-I [J].

Backeljauw, Philippe F. ;

Kuntze, Joyce ;

Frane, James ;

Calikoglu, Ali S. ;

Chernausek, Steven D. .

HORMONE RESEARCH IN PAEDIATRICS, 2013, 80 (01) :47-56

[8] Are adult patients with Laron syndrome osteopenic? A comparison between dual-energy X-ray absorptiometry and volumetric bone densities [J].

Benbassat, CA ;

Eshed, V ;

Kamjin, M ;

Laron, Z .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10) :4586-4589

[9]

BERG MA, 1993, AM J HUM GENET, V52, P998

[10] Insulinlike growth factor I affects ocular development - A study of untreated and treated patients with Laron syndrome [J].

Bourla, DH ;

Laron, Z ;

Snir, M ;

Lilos, P ;

Weinberger, D ;

Axer-Siegel, R .

OPHTHALMOLOGY, 2006, 113 (07) :1197-1200

← 1 2 3 4 5 6 7 8 9 10 →